{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:25:14Z","timestamp":1791494714591,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,4,11]],"date-time":"2008-04-11T00:00:00Z","timestamp":1207872000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s11154-008-9074-4","type":"journal-article","created":{"date-parts":[[2008,4,10]],"date-time":"2008-04-10T16:42:11Z","timestamp":1207845731000},"page":"153-160","source":"Crossref","is-referenced-by-count":124,"title":["Osteogenesis Imperfecta: Update on presentation and management"],"prefix":"10.1007","volume":"9","author":[{"given":"Moira S.","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis H.","family":"Glorieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,11]]},"reference":[{"key":"9074_CR1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet 2004;363:1377\u201385.","journal-title":"Lancet"},{"key":"9074_CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.22203\/eCM.v005a04","volume":"5","author":"PJ Roughley","year":"2003","unstructured":"Roughley PJ, Rauch F, Glorieux FH. Osteogenesis imperfecta\u2014clinical and molecular diversity. Eur Cell Mater. 2003;5:41\u20137. discussion 47.","journal-title":"Eur Cell Mater"},{"key":"9074_CR3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s002239900600","volume":"64","author":"A Boyde","year":"1999","unstructured":"Boyde A, Travers R, Glorieux FH, Jones SJ. The mineralization density of iliac crest bone from children with osteogenesis imperfecta. Calcif Tissue Int. 1999;64:185\u201390.","journal-title":"Calcif Tissue Int"},{"key":"9074_CR4","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","volume":"15","author":"FH Glorieux","year":"2000","unstructured":"Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux DF, Fassier F, Bishop NJ. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res. 2000;15:1650\u20138.","journal-title":"J Bone Miner Res"},{"key":"9074_CR5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1359\/jbmr.2002.17.1.30","volume":"17","author":"FH Glorieux","year":"2002","unstructured":"Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res. 2002;17:30\u20138.","journal-title":"J Bone Miner Res"},{"key":"9074_CR6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S8756-3282(02)00790-1","volume":"31","author":"LM Ward","year":"2002","unstructured":"Ward LM, Rauch F, Travers R, Chabot G, Azouz EM, Lalic L, Roughley PJ, Glorieux FH. Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone 2002;31:12\u20138.","journal-title":"Bone"},{"key":"9074_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","volume":"127","author":"R Morello","year":"2006","unstructured":"Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, Bachinger HP, Pace JM, Schwarze U, Byers PH, Weis M, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B. CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 2006;127:291\u2013304.","journal-title":"Cell"},{"key":"9074_CR8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ng1968","volume":"39","author":"WA Cabral","year":"2007","unstructured":"Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, Makareeva E, Kuznetsova NV, Rosenbaum KN, Tifft CJ, Bulas DI, Kozma C, Smith PA, Eyre DR, Marini JC. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal\/severe osteogenesis imperfecta. Nat Genet. 2007;39:359\u201365.","journal-title":"Nat Genet"},{"key":"9074_CR9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.gim.0000223557.54670.aa","volume":"8","author":"PH Byers","year":"2006","unstructured":"Byers PH, Krakow D, Nunes ME, Pepin M. Genetic evaluation of suspected osteogenesis imperfecta (OI). Genet Med. 2006;8:383\u20138.","journal-title":"Genet Med"},{"key":"9074_CR10","first-page":"66","volume":"97","author":"R Cubert","year":"2001","unstructured":"Cubert R, Cheng EY, Mack S, Pepin MG, Byers PH. Osteogenesis imperfecta: mode of delivery and neonatal outcome. Obstet Gynecol. 2001;97:66\u20139.","journal-title":"Obstet Gynecol"},{"key":"9074_CR11","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1359\/JBMR.050213","volume":"20","author":"CF Munns","year":"2005","unstructured":"Munns CF, Rauch F, Travers R, Glorieux FH. Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome. J Bone Miner Res. 2005;20:1235\u201343.","journal-title":"J Bone Miner Res"},{"key":"9074_CR12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.molmed.2005.01.004","volume":"11","author":"MA Koay","year":"2005","unstructured":"Koay MA, Brown MA. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton. Trends Mol Med. 2005;11:129\u201337.","journal-title":"Trends Mol Med"},{"key":"9074_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01202412-199801000-00006","volume":"7","author":"EJ Breslau-Siderius","year":"1998","unstructured":"Breslau-Siderius EJ, Engelbert RH, Pals G, van der Sluijs JA. Bruck syndrome: a rare combination of bone fragility and multiple congenital joint contractures. J Pediatr Orthop B. 1998;7:35\u20138.","journal-title":"J Pediatr Orthop B"},{"key":"9074_CR14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-3476(87)80292-5","volume":"110","author":"DE Cole","year":"1987","unstructured":"Cole DE, Carpenter TO. Bone fragility, craniosynostosis, ocular proptosis, hydrocephalus, and distinctive facial features: a newly recognized type of osteogenesis imperfecta. J Pediatr. 1987;110:76\u201380.","journal-title":"J Pediatr"},{"key":"9074_CR15","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1359\/jbmr.2000.15.5.957","volume":"15","author":"F Rauch","year":"2000","unstructured":"Rauch F, Travers R, Norman ME, Taylor A, Parfitt AM, Glorieux FH. Deficient bone formation in idiopathic juvenile osteoporosis: a histomorphometric study of cancellous iliac bone. J Bone Miner Res. 2000;15:957\u201363.","journal-title":"J Bone Miner Res"},{"key":"9074_CR16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1210\/jc.2002-021371","volume":"88","author":"F Rauch","year":"2003","unstructured":"Rauch F, Plotkin H, Travers R, Zeitlin L, Glorieux FH. Osteogenesis imperfecta types I, III and IV: effect of pamidronate therapy on bone and mineral metabolism. J Clin Endocrinol Metab. 2003;88:986\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"9074_CR17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bone.2007.05.002","volume":"41","author":"CF Munns","year":"2007","unstructured":"Munns CF, Rajab MH, Hong J, Briody J, Hogler W, McQuade M, Little DG, Cowell CT. Acute phase response and mineral status following low dose intravenous zoledronic acid in children. Bone 2007;41:366\u201370.","journal-title":"Bone"},{"key":"9074_CR18","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","volume":"339","author":"FH Glorieux","year":"1998","unstructured":"Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998;339:947\u201352.","journal-title":"N Engl J Med"},{"key":"9074_CR19","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1542\/peds.111.5.e601","volume":"111","author":"K Montpetit","year":"2003","unstructured":"Montpetit K, Plotkin H, Rauch F, Bilodeau N, Cloutier S, Rabzel M, Glorieux FH. Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta. Pediatrics. 2003;111:e601\u20133.","journal-title":"Pediatrics"},{"key":"9074_CR20","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","volume":"111","author":"L Zeitlin","year":"2003","unstructured":"Zeitlin L, Rauch F, Plotkin H, Glorieux FH. Height and weight development during long-term therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III and IV. Pediatrics 2003;111:1030\u20136.","journal-title":"Pediatrics"},{"key":"9074_CR21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.bone.2006.10.010","volume":"40","author":"C Land","year":"2007","unstructured":"Land C, Rauch F, Travers R, Glorieux FH. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment. Bone 2007;40:638\u201344.","journal-title":"Bone"},{"key":"9074_CR22","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1359\/JBMR.040303","volume":"19","author":"F Rauch","year":"2004","unstructured":"Rauch F, Travers R, Munns C, Glorieux FH. Sclerotic metaphyseal lines in a child treated with pamidronate: histomorphometric analysis. J Bone Miner Res. 2004;19:1191\u20133.","journal-title":"J Bone Miner Res"},{"key":"9074_CR23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bone.2006.04.004","volume":"39","author":"C Land","year":"2006","unstructured":"Land C, Rauch F, Munns CF, Sahebjam S, Glorieux FH. Vertebral morphometry in children and adolescents with osteogenesis imperfecta: Effect of intravenous pamidronate treatment. Bone 2006;39:901\u20136.","journal-title":"Bone"},{"key":"9074_CR24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/jc.2005-2036","volume":"91","author":"F Rauch","year":"2006","unstructured":"Rauch F, Travers R, Glorieux FH. Pamidronate in children with osteogenesis imperfecta: histomorphometric effects of long-term therapy. J Clin Endocrinol Metab. 2006;91:511\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"9074_CR25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bone.2004.03.008","volume":"35","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Mier RJ, Glorieux FH. Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta. Bone 2004;35:231\u20134.","journal-title":"Bone"},{"key":"9074_CR26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1359\/JBMR.051207","volume":"21","author":"C Land","year":"2006","unstructured":"Land C, Rauch F, Glorieux FH. Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta. J Bone Miner Res. 2006;21:374\u20139.","journal-title":"J Bone Miner Res"},{"key":"9074_CR27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","volume":"7","author":"CA Migliorati","year":"2006","unstructured":"Migliorati CA, Siegel MA, Elting LS. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol. 2006;7:508\u201314.","journal-title":"Lancet Oncol"},{"key":"9074_CR28","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1359\/JBMR.040814","volume":"19","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH. Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res. 2004;19:1779\u201386.","journal-title":"J Bone Miner Res"},{"key":"9074_CR29","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1359\/JBMR.040711","volume":"19","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Ward L, Glorieux FH. Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases. J Bone Miner Res. 2004;19:1742\u20135.","journal-title":"J Bone Miner Res"},{"key":"9074_CR30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.bpo.0000189007.55174.7c","volume":"26","author":"M Aarabi","year":"2006","unstructured":"Aarabi M, Rauch F, Hamdy RC, Fassier F. High prevalence of coxa vara in patients with severe osteogenesis imperfecta. J Pediatr Orthop. 2006;26:24\u20138.","journal-title":"J Pediatr Orthop"},{"key":"9074_CR31","first-page":"622","volume":"22","author":"P Violas","year":"2002","unstructured":"Violas P, Fassier F, Hamdy R, Duhaime M, Glorieux FH. Acetabular protrusion in osteogenesis imperfecta. J Pediatr Orthop. 2002;22:622\u20135.","journal-title":"J Pediatr Orthop"},{"key":"9074_CR32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1359\/jbmr.2003.18.2.237","volume":"18","author":"JC Marini","year":"2003","unstructured":"Marini JC, Hopkins E, Glorieux FH, Chrousos GP, Reynolds JC, Gundberg CM, Reing CM. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen. J Bone Miner Res. 2003;18:237\u201343.","journal-title":"J Bone Miner Res"},{"key":"9074_CR33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","volume":"30","author":"JL Vahle","year":"2002","unstructured":"Vahle JL, Sato M, Long GG, Young JK, Francis PC, Engelhardt JA, Westmore MS, Linda Y, Nold JB. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1\u201334) for 2\u00a0years and relevance to human safety. Toxicol Pathol. 2002;30:312\u201321.","journal-title":"Toxicol Pathol"},{"key":"9074_CR34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/6529","volume":"5","author":"EM Horwitz","year":"1999","unstructured":"Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309\u201313.","journal-title":"Nat Med"},{"key":"9074_CR35","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood.V97.5.1227","volume":"97","author":"EM Horwitz","year":"2001","unstructured":"Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, McCarville ME, Orchard PJ, Pyeritz RE, Brenner MK. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001;97:1227\u201331.","journal-title":"Blood"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-008-9074-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-008-9074-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-008-9074-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T08:31:21Z","timestamp":1559377881000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-008-9074-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,11]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["9074"],"URL":"https:\/\/doi.org\/10.1007\/s11154-008-9074-4","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,11]]}}}